Back to News
Market Impact: 0.25

Noteworthy Monday Option Activity: MA, REGN, AMC

AGRAMCDMAFXRITWMANDAQREGN
Derivatives & VolatilityFutures & OptionsCompany FundamentalsHealthcare & BiotechMarket Technicals & Flows
Noteworthy Monday Option Activity: MA, REGN, AMC

Regeneron Pharmaceuticals (REGN) options are exhibiting heightened activity, with total volume reaching 50.1% of its average daily share volume, driven by significant interest in the $1000 strike call option expiring December 2026. Similarly, AMC Entertainment (AMC) options are showing strong volume, accounting for 49.1% of its average daily share volume, with notable activity in the $3.50 strike call option expiring June 2025.

Analysis

Regeneron Pharmaceuticals (REGN) and AMC Entertainment (AMC) are both experiencing notable increases in options trading activity. REGN's options volume reached 8,017 contracts, equivalent to approximately 801,700 underlying shares, which constitutes a significant 50.1% of its average daily share trading volume of 1.6 million shares over the past month. A substantial portion of this activity is concentrated in the $1000 strike call option expiring December 18, 2026, with 2,659 contracts traded, representing about 265,900 underlying shares. Similarly, AMC Entertainment saw options volume of 73,638 contracts, or approximately 7.4 million underlying shares, accounting for 49.1% of its 15.0 million average daily share volume. For AMC, the $3.50 strike call option expiring June 13, 2025, was particularly active, with 9,169 contracts changing hands, corresponding to roughly 916,900 underlying shares. This heightened options activity, while accompanied by a neutral overall sentiment signal and a low market impact score, points to increased trader focus and potential anticipation of future price movements or sophisticated hedging strategies in these specific names, particularly around the highlighted long-dated and strike-specific call options.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo